Navigation Links
Using evolution, UW team creates a template for many new therapeutic agents
Date:9/9/2007

MADISON - By guiding an enzyme down a new evolutionary pathway, a team of University of Wisconsin-Madison researchers has created a new form of an enzyme capable of producing a range of potential new therapeutic agents with anticancer and antibiotic properties.

Writing in the current issue (Sept. 9, 2007) of the journal Nature Chemical Biology, a team of researchers from the UW-Madison School of Pharmacy describes a novel enzyme capable of changing the chemical properties of a variety of existing drugs and small molecules to make new agents to treat cancer and fight infection.

"We're finding this enzyme glycosylates all sorts of molecules," says Jon Thorson, a UW-Madison professor of pharmaceutical sciences describing the process of adding natural sugar molecules to other chemical molecules to enhance their biological effects.

The newly evolved enzyme developed by Thorson and colleagues Gavin. J. Williams and Changsheng Zhang, according to Thorson, is akin to a "Swiss Army enzyme," a catalyst that can decorate many different chemical molecules with all sorts of sugars to alter their biological effects.

Enzymes are proteins that act as catalysts across biology, from single-celled organisms to humans. They promote chemical reactions in cells and are used widely in industry for everything from making beer and cheese to producing paper and biofuel.

They are also important for making so-called natural drugs, therapeutic agents based on the blueprints of chemicals produced in nature by plants and microorganisms. Such natural sugar-bearing chemicals are the basis for some of medicine's most potent antibiotics and anticancer drugs as exemplified by the antibiotic erythromycin and the anticancer drug doxorubicin.

Important chemical features of such drugs are natural sugars, molecules that often determine a chemical compound's biological effects. Although scientists can sometimes manipulate how sugars are added or
'/>"/>

Contact: Jon Thorson
jsthorson@pharmacy.wisc.edu
608-262-3829
University of Wisconsin-Madison
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. Purdue proves concept of using nano-materials for drug discovery
3. An entropy-based gene selection method for cancer classification using microarray data
4. Newly Discovered Compound Blocks Known Cancer-Causing Protein
5. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
6. New methods of gene delivery using lasers
7. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
8. Doctors closer to using gene analysis to help trauma patients
9. PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information
10. Researchers pioneer new gene therapy technique using natural repair process
11. Researchers Closer To Helping Hearing-Impaired Using Stem Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...Nov. 4 Glencoe Software, Inc., the... (OME) Consortium ( http://openmicroscopy.org ),...merican Society of Cell Biology,s exciting new pro... has been awarded a $2.5M stimulus grant through t...ortunities program, as part of the American Reinve...
(Date:11/3/2009)...PAINIn a research report published in a recent iss... and Sim Alegre examined the effects of covering o..., fruit quality, canopy light distribution, orchar...were performed using Extenday and Solarmate films ...hards of ,Mondial Gala, apples. The research showe...
(Date:11/3/2009)...rom the UCLA Henry Samueli School of Engineering a...fully reconstituted in the laboratory the enzyme r...ol-lowering drug lovastatin. , The research, ...potentially lead to the development of other compo... lovastatin-synthesizing enzyme is one of the most...
Breaking Biology News(10 mins):Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2Scientists identify specific markers that trigger aggressiveness of liver cancer 59827 1Scientists identify specific markers that trigger aggressiveness of liver cancer 59827 2Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 1Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 2New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 1New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 2New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 3
...year worldwide, causing one million deaths. Around...ung children. One of the greatest challenges facin...stance; resistance to chloroquine (CQ), the cheape...roughout Africa, and resistance to sulfadoxine-pyr...ensive alternative to CQ, is also increasing. Thes...
... is harmless on human skin, but it is the leading ...ns of indwelling medical devices. S. epidermidis i... in people with prosthetic joints, replacement hea...ic resistance makes it tough to battle. Moreover, ...o pathogenic once the protective barrier of the sk...
...cess by which a single gene can initiate productio...ive splicing, said Baylor College of Medicine rese...of the journal Molecular Cell. "A major question i...es produce at least 120,000 proteins," said Dr. Be...lar and cellular biology. The answer is a process ...
Other Biology News:Reducing malarial transmission in Africa 2Controlling protein diversity 2
(Date:11/5/2009)...ov. 5 DSM Pharmaceutical Products ...lliance with Galenix, Saint Jean D,Illac, France, ...anufacturing partner for Galenix commercial produc...ollaborate on business development opportunities c...sed on the strength of Galenix in drug product dev...
(Date:11/5/2009).... 5 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
(Date:11/5/2009)... 5 SpineSmith Partners has signed ...elop a unique scaffold that mimics the structure o...f several commercial products by SpineSmith,s Rese...ves the GenOsteo scaffold represents a significant...nd ideal environment for the delivery of adult ste...
(Date:11/4/2009)... This webinar, which will be presented on November...uous flow chemistry processing, will deal with the... various meso and micro scale flow chemistry equip...ns has been recognized with several prestigious pr...Tetrahedron Prize. , Colu...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...,Inc. (Nasdaq: ARNA ) today announced it will rep...e NASDAQ Global Market closes on Tuesday, August,5...esident and Chief,Executive Officer, and Robert E....f Financial Officer, will host a conference call a...to discuss the second quarter 2008,financial resul...
...,local forensic crime labs received evidence from ...uring 2005, according to a report by the Justice,D...ese cases included,requests for a variety of foren...tance identification, and fingerprint examination....not completed within 30,days) at the end of 2005--...
...ting, Standards and Procedures, SHAANXI, China, J...o-,Pharmaceutical Technology, Inc. (OTC Bulletin B...lant extracts and raw materials used in the,produc...roduction, today,released an investor update on th...he delivery of Diosmin to Safic-Alcan., COS, or E...
Other Biology Technology:Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008 2Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008 3Crime Labs Received an Estimated 2.7 Million Cases in 2005 2Crime Labs Received an Estimated 2.7 Million Cases in 2005 3Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 2Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 3
...AQ systems integrate the unique quantitative and q...0 Q TRAP LC/MS/MS Systems with the new Tempo nano ... rapid solution for high sensitivity validation of...le preparation with high instrument selectivity an...
...XL extends the legendary MSn performance of the LT...tural information through Thermo Scientifics innov...s LTQ XL is the only mass spectrometer that offers...D. Pulsed Q Collision Induced Dissociation (PQD) ...
...orefront of Agilent analytical solutions is the 68... networking (LAN) allows you to share business and...ed decision making. Just as its 6890 GC predecesso...e needed for research and method development in an...
Varian CP-4900 Micro-GC from Varian, Inc.
Biology Products: